{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:27:41Z","timestamp":1777566461753,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00436-018-5967-7","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T02:01:43Z","timestamp":1529632903000},"page":"2795-2805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A new iron(III) complex-containing sulfadiazine inhibits the proliferation and induces cystogenesis of Toxoplasma gondii"],"prefix":"10.1007","volume":"117","author":[{"given":"Juliana de A.","family":"Portes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nath\u00e1lia F. B.","family":"Azeredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro G. T.","family":"Siqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana Guinancio","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Adolfo","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalber R. S.","family":"Candela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanderley","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato A.","family":"DaMatta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9rgio H.","family":"Seabra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"key":"5967_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4314\/bcse.v22i2.61295","volume":"22","author":"PA Ajibade","year":"2008","unstructured":"Ajibade PA, Kolawole GA (2008) Synthesis, characterization, antiplasmodial and antitrypanosomal activity of some metal(III) complexes of sulfadiazine. Bull Chem Soc Ethiop 22:261\u2013268. \n                    https:\/\/doi.org\/10.4314\/bcse.v22i2.61295","journal-title":"Bull Chem Soc Ethiop"},{"key":"5967_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1128\/AAC.35.2.293","volume":"35","author":"FG Araujo","year":"1991","unstructured":"Araujo FG, Huskinson J, Remington JS (1991) Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii. Antimicrob Agents Chemother 35:293\u2013299. \n                    https:\/\/doi.org\/10.1128\/AAC.35.2.293","journal-title":"Antimicrob Agents Chemother"},{"key":"5967_CR3","doi-asserted-by":"publisher","first-page":"100606","DOI":"10.1039\/C5RA17690E","volume":"5","author":"LC Batista","year":"2015","unstructured":"Batista LC, De Souza FS, De Assis VM, Seabra SH, Bortoluzzi AJ, Renn\u00f3 MN, Horn A Jr, DaMatta RA, Fernandes C (2015) Antiproliferative activity and conversion of tachyzoite too bradyzoite of Toxoplasma gondii promoted by new zinc complexes containing sufadiazine. RSC Adv 5:100606\u2013100617. \n                    https:\/\/doi.org\/10.1039\/C5RA17690E","journal-title":"RSC Adv"},{"key":"5967_CR4","first-page":"214","volume":"119","author":"F Bertoli","year":"1995","unstructured":"Bertoli F, Espino M, Arosemena JR, Fishback JL, Frenkel JK (1995) A spectrum in the pathology of toxoplasmosis in patients with acquired immune deficiency syndrome. Arch Pathol Lab Med 119:214\u2013224","journal-title":"Arch Pathol Lab Med"},{"key":"5967_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejmech.2016.07.018","volume":"123","author":"LJH Borges","year":"2016","unstructured":"Borges LJH, Bull \u00c9S, Fernandes C, Horn A Jr, Azeredo NF, JALC R, Freitas WR, ECQ C, Lemos LS, Jerdy H, Kanashiro MM (2016) In vitro and in vivo studies of the antineoplastic activity of copper (II) compounds against human leukemia THP-1 and murine melanoma B16-F10 cell lines. Eur J Med Chem 123:128\u2013140. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2016.07.018","journal-title":"Eur J Med Chem"},{"key":"5967_CR6","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jinorgbio.2011.03.015","volume":"105","author":"AB Caballero","year":"2011","unstructured":"Caballero AB, Mar\u00edn C, Rodr\u00edguez-Di\u00e9guez A, Ram\u00edrez-Mac\u00edas I, Barea E, S\u00e1nchez-Moreno M, Salas JM (2011) In vitro and in vivo antiparasital activity against Trypanosoma cruzi of three novel 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one-based complexes. J Inorg Biochem 105:770\u2013776. \n                    https:\/\/doi.org\/10.1016\/j.jinorgbio.2011.03.015","journal-title":"J Inorg Biochem"},{"key":"5967_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jinorgbio.2011.12.007","volume":"109","author":"A Casini","year":"2012","unstructured":"Casini A (2012) Exploring the mechanisms of metal-based pharmacological agents via an integrated approach. J Inorg Biochem 109:97\u2013106. \n                    https:\/\/doi.org\/10.1016\/j.jinorgbio.2011.12.007","journal-title":"J Inorg Biochem"},{"key":"5967_CR8","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.parint.2015.08.010","volume":"64","author":"LLR Silva Da","year":"2015","unstructured":"Da Silva LLR, Portes JA, De Ara\u00fajo MH, Silva JLS, Renn\u00f3 MN, Netto CD, Da Silva AJM, Costa PRR, De Souza W, Seabra SH, DaMatta RA (2015) Further evidence that naphthoquinone inhibits Toxoplasma gondii growth in vitro. Parasitol Int 64:622\u2013631. \n                    https:\/\/doi.org\/10.1016\/j.parint.2015.08.010","journal-title":"Parasitol Int"},{"issue":"10","key":"5967_CR9","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1128\/AAC.33.10.1753","volume":"33","author":"F Derouin","year":"1989","unstructured":"Derouin F, Chastang C (1989) In vitro effects of folate inhibitors on Toxoplasma gondii. Antimicrob Agents Chemother 33(10):1753\u20131759. \n                    https:\/\/doi.org\/10.1128\/AAC.33.10.1753","journal-title":"Antimicrob Agents Chemother"},{"key":"5967_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.micinf.2004.09.016","volume":"7","author":"O Djurkovic-Djakovic","year":"2005","unstructured":"Djurkovic-Djakovic O, Nikolic A, Bobic B, Klun I, Aleksic A (2005) Stage conversion of Toxoplasma gondii RH parasites in mice by treatment with atovaquone and pyrrolidine dithiocarbamate. Microbes Infect 7:49\u201354. \n                    https:\/\/doi.org\/10.1016\/j.micinf.2004.09.016","journal-title":"Microbes Infect"},{"key":"5967_CR11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/CMR.11.2.267","volume":"11","author":"JP Dubey","year":"1998","unstructured":"Dubey JP, Lindsay DS, Speer CA (1998) Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev 11:267\u2013299","journal-title":"Clin Microbiol Rev"},{"key":"5967_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijpara.2005.08.014","volume":"36","author":"MS Eaton","year":"2006","unstructured":"Eaton MS, Weiss LM, Kim K (2006) Cyclic nucleotide kinases and tachyzoite-bradyzoite transition in Toxoplasma gondii. Int J Parasitol 36:107\u2013114. \n                    https:\/\/doi.org\/10.1016\/j.ijpara.2005.08.014","journal-title":"Int J Parasitol"},{"key":"5967_CR13","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jinorgbio.2010.07.011","volume":"104","author":"C Fernandes","year":"2010","unstructured":"Fernandes C, Horn A Jr, Vieira-da-Motta O, de Assis VM, Rocha MR, Mathias LS, Bull ES, Bortoluzzi AJ, Guimar\u00e3es EV, Almeida JCA, Russell DH (2010) Synthesis, characterization and antibacterial activity of FeIII, CoII, CuII and ZnII complexes probed by transmission electron microscopy. J Inorg Biochem 104:1214\u20131223. \n                    https:\/\/doi.org\/10.1016\/j.jinorgbio.2010.07.011","journal-title":"J Inorg Biochem"},{"key":"5967_CR14","doi-asserted-by":"publisher","first-page":"11498","DOI":"10.1039\/C7NJ01164D","volume":"41","author":"CA Gomes","year":"2017","unstructured":"Gomes CA, Lube LM, Fernandes C, Franco RWA, Resende JALC, Horn A Jr (2017) A new system for cyclohexane functionalization employing iron(III) catalysts and trichloroisocyanuric acid. New J Chem 41:11498\u201311502. \n                    https:\/\/doi.org\/10.1039\/C7NJ01164D","journal-title":"New J Chem"},{"key":"5967_CR15","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1016\/j.jinorgbio.2005.09.001","volume":"99","author":"W Guerra","year":"2005","unstructured":"Guerra W, Azevedo EA, Monteiro ARS, Bucciarelli-Rodriguez M, Chartone-Souza E, Nascimento AMA, Fontes APS, Le Moyec L, Pereira-Maia EC (2005) Synthesis, characterization, and antibacterial activity of three palladium(II) complexes of tetracyclines. J Inorg Biochem 99:2348\u20132354. \n                    https:\/\/doi.org\/10.1016\/j.jinorgbio.2005.09.001","journal-title":"J Inorg Biochem"},{"key":"5967_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3144\/expresspolymlett.2007.26","volume":"1","author":"J Guo","year":"2007","unstructured":"Guo J, Li L, Ti Y, Zhu J (2007) Synthesis and properties of a novel pH sensitive poly(N-vinyl-pyrrolidone-co-sulfadiazine) hydrogel. Express Polym Lett 1:166\u2013172. \n                    https:\/\/doi.org\/10.3144\/expresspolymlett.2007.26","journal-title":"Express Polym Lett"},{"key":"5967_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/B978-0-444-53490-3.00008-X","volume":"114","author":"SK Halonen","year":"2013","unstructured":"Halonen SK, Weiss LM (2013) Toxoplasmosis. Handb Clin Neurol 114:125\u2013145. \n                    https:\/\/doi.org\/10.1016\/B978-0-444-53490-3.00008-X","journal-title":"Handb Clin Neurol"},{"key":"5967_CR18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.molstruc.2006.03.043","volume":"797","author":"A Horn Jr","year":"2006","unstructured":"Horn A Jr, Fim L, Bortoluzzi AJ, Szpoganicz B, Silva MS, Novak MA, Neto MB, Eberlin LS, Catharino RR, Eberlin MN, Fernandes C (2006) Solid state and solution characterization of a new dinuclear nickel (II) complex: the search for synthetic models for urease. J Mol Struct 797:154\u2013164. \n                    https:\/\/doi.org\/10.1016\/j.molstruc.2006.03.043","journal-title":"J Mol Struct"},{"key":"5967_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/rem.20068","volume":"16","author":"A Jones-Lee","year":"2005","unstructured":"Jones-Lee A, Lee GF (2005) Role of iron chemistry in controlling the release of pollutants from resuspended sediments. Remediation J 16:33\u201341. \n                    https:\/\/doi.org\/10.1002\/rem.20068","journal-title":"Remediation J"},{"key":"5967_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/1545109707301244","volume":"7","author":"S Kongsaengdao","year":"2008","unstructured":"Kongsaengdao S, Samintarapanya K, Oranratnachai K, Prapakarn W, Apichartpiyakul C (2008) Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients. J Int Assoc Phys AIDS Care 7:11\u201316. \n                    https:\/\/doi.org\/10.1177\/1545109707301244","journal-title":"J Int Assoc Phys AIDS Care"},{"key":"5967_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S1471-4922(01)02093-1","volume":"17","author":"CG L\u00fcder","year":"2001","unstructured":"L\u00fcder CG, Bohne W, Soldati D (2001) Toxoplasmosis: a persisting challenge. Trends Parasitol 17:460\u2013463. \n                    https:\/\/doi.org\/10.1016\/S1471-4922(01)02093-1","journal-title":"Trends Parasitol"},{"key":"5967_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/clinids\/15.2.211","volume":"15","author":"BJ Luft","year":"1992","unstructured":"Luft BJ, Remington JS (1992) Toxoplasmic encephalitis in AIDS. Clin Infect Dis 15:211\u2013222","journal-title":"Clin Infect Dis"},{"key":"5967_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.apcata.2015.09.035","volume":"507","author":"PMA Machado","year":"2015","unstructured":"Machado PMA, Lube LM, Tiradentes MDE, Fernandes C, Gomes CA, Stumbo AM, San Gil RAS, Visentin LC, Sanchez CR, Frescura VLA, Silva JSA, Horn A Jr (2015) Synthesis, characterization and activity of homogeneous and heterogeneous (SiO2, NaY, MCM-41) iron(III) catalysts on cyclohexane and cyclohexene oxidation. Appl Catal A Gen 507:119\u2013129. \n                    https:\/\/doi.org\/10.1016\/j.apcata.2015.09.035","journal-title":"Appl Catal A Gen"},{"key":"5967_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.vetpar.2010.11.034","volume":"177","author":"ES Martins-Duarte","year":"2010","unstructured":"Martins-Duarte ES, Lemgruber L, Lorente SO, Gros L, Magaraci F, Gilbert IH, De Souza W, Vommaro RC (2010) Evaluation of three novel azasterols against Toxoplasma gondii. Vet Parasitol 177:157\u2013161. \n                    https:\/\/doi.org\/10.1016\/j.vetpar.2010.11.034","journal-title":"Vet Parasitol"},{"key":"5967_CR25","doi-asserted-by":"publisher","unstructured":"McCann M,\u00a0Curran R,\u00a0Ben-Shoshan M,\u00a0McKee V,\u00a0Tahir AA,\u00a0Devereux M,\u00a0Kavanagh K,\u00a0Creaven BS,\u00a0Kellett A (2012) Silver(I)\u00a0complexes\u00a0of\u00a09-anthracenecarboxylic\u00a0acid\u00a0and\u00a0imidazoles:\u00a0synthesis,\u00a0structure\u00a0and\u00a0antimicrobial\u00a0activity. Dalton Trans\u00a041(21):6516\u20136527. \n                    https:\/\/doi.org\/10.1039\/c2dt12166b","DOI":"10.1039\/c2dt12166b"},{"key":"5967_CR26","doi-asserted-by":"publisher","first-page":"bcr2012006638","DOI":"10.1136\/bcr-2012-006638","volume":"2012","author":"BD McGettigan","year":"2012","unstructured":"McGettigan BD, Hew M, Phillips E, McLean-Tooke A (2012) Sulphadiazine-induced renal stones in a 63-year-old HIV-infected man treated for toxoplasmosis. BMJ Case Reports 2012:bcr2012006638. \n                    https:\/\/doi.org\/10.1136\/bcr-2012-006638","journal-title":"BMJ Case Reports"},{"key":"5967_CR27","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1128\/AAC.01203-07","volume":"52","author":"P Meneceur","year":"2008","unstructured":"Meneceur P, Bouldouyre MA, Aubert D, Villena I, Menotti J, Sauvage V, Garin JF, Derouin F (2008) Toxoplasma gondii: in vitro susceptibility of various genotypic strains to pyrimethamine, sulfadiazine and atovaquone. Antimicrob Agents Chemother 52:1269\u20131277. \n                    https:\/\/doi.org\/10.1128\/AAC.01203-07","journal-title":"Antimicrob Agents Chemother"},{"key":"5967_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.micron.2008.08.003","volume":"40","author":"RF Menna-Barreto","year":"2009","unstructured":"Menna-Barreto RF, Salomao K, Dantas AP, Santa-Rita RM, Soares MJ, Barbosa HS, De Castro SL (2009) Different cell death pathways induced by drugs in Trypanosoma cruzi: an ultrastructural study. Micron 40:157\u2013168. \n                    https:\/\/doi.org\/10.1016\/j.micron.2008.08.003","journal-title":"Micron"},{"key":"5967_CR29","first-page":"291","volume":"69","author":"B Milewska-Bobula","year":"2015","unstructured":"Milewska-Bobula B, Lipka B, Go\u0142\u0105b E, D\u0119bski R, Marczy\u0144ska M, Paul M, Panasiuk A, Seroczy\u0144ska M, Mazela J, Dunin-W\u0105sowicz D (2015) Recommended management of Toxoplasma gondii infection in pregnant women and their children. Przegl Epidemiol 69:291\u2013298","journal-title":"Przegl Epidemiol"},{"key":"5967_CR30","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"JG Montoya","year":"2004","unstructured":"Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965\u20131976. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(04)16412-X","journal-title":"Lancet"},{"key":"5967_CR31","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s11094-006-0162-z","volume":"79","author":"HM Parekh","year":"2005","unstructured":"Parekh HM, Pansuriya PB, Patel MN (2005) Characterization and antifungal study of genuine oxovanadium (IV) mixed-ligand complexes with Schiff bases. Pol J Chem 79:1843\u20131851. \n                    https:\/\/doi.org\/10.1007\/s11094-006-0162-z","journal-title":"Pol J Chem"},{"key":"5967_CR32","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1645\/GE-2712.1","volume":"97","author":"HJ Peng","year":"2011","unstructured":"Peng HJ, Chen XG, Lindsay DS (2011) A review: competence, compromise, and concomitance reaction of the host cell to Toxoplasma gondii infection and development. J Parasitol 97:620\u2013628. \n                    https:\/\/doi.org\/10.1645\/GE-2712.1","journal-title":"J Parasitol"},{"key":"5967_CR33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.vetpar.2011.11.008","volume":"186","author":"JA Portes","year":"2012","unstructured":"Portes JA, Netto CD, Da Silva AJM, Costa PRR, DaMatta RA, Dos Santos TAT, De Souza W, Seabra SH (2012) A new type of pterocarpanquinone that affects Toxoplasma gondii tachyzoites in vitro. Vet Parasitol 186:261\u2013269. \n                    https:\/\/doi.org\/10.1016\/j.vetpar.2011.11.008","journal-title":"Vet Parasitol"},{"issue":"12","key":"5967_CR34","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.1128\/AAC.00057-15","volume":"59","author":"JDA Portes","year":"2015","unstructured":"Portes JDA, De Souza TG, Santos TAT, Da Silva LLR, Ribeiro TP, Pereira MD, Junior AH, Fernandes C, Damatta RA, De Souza W, Seabra SH (2015) Reduction of Toxoplasma gondii development due to inhibition of parasite antioxidant enzymes by a dinuclear iron(III) compound. Antimicrob Agents Chemother 59(12):7374\u20137386. \n                    https:\/\/doi.org\/10.1128\/AAC.00057-15","journal-title":"Antimicrob Agents Chemother"},{"key":"5967_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.vetpar.2017.04.002","volume":"245","author":"JA Portes","year":"2017","unstructured":"Portes JA, Motta CS, Azeredo NF, Fernandes C, Horn A Jr, De Souza W, DaMatta RA, Seabra SH (2017) In vitro treatment of Toxoplasma gondii with copper(II) complexes induces apoptosis-like and cellular division alterations. Vet Parasitol 245:141\u2013152. \n                    https:\/\/doi.org\/10.1016\/j.vetpar.2017.04.002","journal-title":"Vet Parasitol"},{"key":"5967_CR36","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/jac\/dkq537","volume":"66","author":"I Ram\u00edrez-Mac\u00edas","year":"2011","unstructured":"Ram\u00edrez-Mac\u00edas I, Mar\u00edn C, Salas JM, Caballero A, Rosales MJ, Villegas N, Rodr\u00edguez-Dieguez A, Barea E, S\u00e1nchez-Moreno M (2011) Biological activity of three novel complexes with the ligand 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one against Leishmania spp. J Antimicrob Chemother 66:813\u2013819. \n                    https:\/\/doi.org\/10.1093\/jac\/dkq537","journal-title":"J Antimicrob Chemother"},{"key":"5967_CR37","doi-asserted-by":"publisher","unstructured":"Riss TL, Moravec RA (2004) Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity\u00a0assays. Assay Drug Dev Technol 2(1):51-62. \n                    https:\/\/doi.org\/10.1089\/154065804322966315","DOI":"10.1089\/154065804322966315"},{"key":"5967_CR38","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.ccr.2006.11.017","volume":"251","author":"L Ronconi","year":"2007","unstructured":"Ronconi L, Sadler PJ (2007) Using coordination chemistry to design new medicines. Coord Chem Rev 251:1633\u20131648. \n                    https:\/\/doi.org\/10.1016\/j.ccr.2006.11.017","journal-title":"Coord Chem Rev"},{"key":"5967_CR39","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cattod.2007.12.036","volume":"133","author":"GC Silva","year":"2008","unstructured":"Silva GC, Parilha GL, Carvalho NMF, Drago V, Fernandes C, Horn A Jr, Antunes OAC (2008) A bio-inspired Fe(III) complex and its use in the cyclohexane oxidation. Catal Today 133:684\u2013688. \n                    https:\/\/doi.org\/10.1016\/j.cattod.2007.12.036","journal-title":"Catal Today"},{"key":"5967_CR40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1515\/9783110470734-021","volume":"5","author":"F Th\u00e9venod","year":"2018","unstructured":"Th\u00e9venod F (2018) Iron and its role in cancer defense: a double-edged sword. Met Ions Life Sci 5:18. \n                    https:\/\/doi.org\/10.1515\/9783110470734-021","journal-title":"Met Ions Life Sci"},{"key":"5967_CR41","first-page":"910","volume":"55","author":"BG Tweedy","year":"1964","unstructured":"Tweedy BG (1964) Plant extracts with metal ions as potential antimicrobial agents. Phytopathology 55:910\u2013914","journal-title":"Phytopathology"},{"key":"5967_CR42","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/S0020-7519(97)00144-6","volume":"27","author":"O Villard","year":"1997","unstructured":"Villard O, Candolfi E, Ferguson DJP, Marcellin L, Kien T (1997) Loss of oral infectivity of tissue cysts of Toxoplasma gondii RH strain to outbred Swiss-Webster mice. Int J Parasitol 27:1555\u20131559. \n                    https:\/\/doi.org\/10.1016\/S0020-7519(97)00144-6","journal-title":"Int J Parasitol"},{"key":"5967_CR43","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/00365549850160963","volume":"30","author":"I Villena","year":"1998","unstructured":"Villena I, Aubert D, Leroux B, Dupouy D, Talmud M, Chemla C, Trenque T, Schmit G, Quereux C, Guenounou M, Pluot M, Bonhomme A, Pinon JM (1998) Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand J Infect Dis 30:295\u2013300","journal-title":"Scand J Infect Dis"},{"key":"5967_CR44","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1550-7408.1995.tb01556.x","volume":"42","author":"LM Weiss","year":"1995","unstructured":"Weiss LM, Laplace D, Takvorian PM, Tanowitz HB, Cali A, Wittner M (1995) A cell culture system for study of the development of Toxoplasma gondii bradyzoites. J Eukaryot Microbiol 42:150\u2013157. \n                    https:\/\/doi.org\/10.1111\/j.1550-7408.1995.tb01556.x","journal-title":"J Eukaryot Microbiol"},{"key":"5967_CR45","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.molmed.2007.04.004","volume":"13","author":"GD Wright","year":"2007","unstructured":"Wright GD, Sutherland AD (2007) New strategies for combating multidrug-resistant bacteria. Trends Mol Med 13:260\u2013267. \n                    https:\/\/doi.org\/10.1016\/j.molmed.2007.04.004","journal-title":"Trends Mol Med"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-018-5967-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-018-5967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-018-5967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T16:36:30Z","timestamp":1581957390000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-018-5967-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["5967"],"URL":"https:\/\/doi.org\/10.1007\/s00436-018-5967-7","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,22]]},"assertion":[{"value":"6 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}